Event category: Concurrent Session

Events

September 05, 2025

2025-09-05

01:15 PM (EDT) - 02:00 PM (EDT)

Paul Wang | J. Peter Weiss

EP Collaboratory to share efforts between industry and early stage companies to promote EFS within the US to increase patient access to new technologies and to support device innovation.

J. Peter Weiss

Cardiac Electrophysiologist

Banner University of Arizona Medical Center Phoenix (BUMCP)

2025-09-05

03:00 PM (EDT) - 03:45 PM (EDT)

Vivek Y. Reddy | Thomas Deneke

By the time of HRX 2025, pulsed field ablation will have been clinically available in the US for more than a year and a half. While first-gen systems have brought notable changes to EP, these first-generation systems only represent the very beginning of PFA. This session will focus on discussion of the key developments and advances for next generation PFA technologies, including advances in pulse sequences, catheter design, integration with electroanatomic mapping, and patient- and anatomic-specific custom lesion formation.

Thomas Deneke

Cardiac Electrophysiologist

Clinic for Arrhythmology, University Heart Center Nuremberg, Paracelsus Medical University

Vivek Y. Reddy

Director of Cardiac Arrhythmia Services

Mount Sinai Health System

2025-09-05

01:15 PM (EDT) - 02:00 PM (EDT)

Steven Lubitz

Catheter ablation has become the dominant form of therapeutic intervention for cardiac arrhythmias. However, preclinical development of new antiarrhythmic drugs is very robust. These new molecular entities are not limited to antagonism of membrane active ion channels, but target additional mechanisms of arrhythmogenesis. These drugs, their targets, and their potential ability to improve and disrupt current care paradigms will be reviewed in this session.

Steven Lubitz

Director of Translational Medicine

Novartis

2025-09-05

02:00 PM (EDT) - 02:45 PM (EDT)

Sanjiv Narayan | Sabine Ernst | Shlomo Shpun | Jennifer N. Avari Silva

Self-driving cars, remote control of drones, and self-navigating planes are all current realities. However, mapping and ablation of cardiac arrhythmias is a completely human and labor-intensive endeavor, despite many advances over the years. This session will discuss the key barriers and potential solutions that may enable remote control of mapping and ablation as well as semi-autonomous systems for mapping and ablation.

Shlomo Shpun

Chief Scientific Office

TechWald Holding S.p.A.

Sabine Ernst

Consultant Cardiologist and Professor of Practice in Cardiology

Imperial College London

Jennifer N. Avari Silva

Director Pediatric Electrophysiology

Washington University SOM

Sanjiv Narayan

Professor of Medicine | Director of the NIH T32 Computational Medicine Training Program (CHIP) | Co-Director of the Arrhythmia Center

Stanford University

2025-09-05

12:30 PM (EDT) - 01:15 PM (EDT)

Avi Fischer | Daniel Cantillon | Malcolm Finlay | Jennifer N. Avari Silva

Not all innovation is successful. Many potential innovations fail in the pre-clinical or early testing phases – often for common reasons. This session will discuss the potential pitfalls in device development and how innovators can navigate these challenges with greater confidence by avoiding mistakes and missteps. The panel will discuss their “dream” innovations that didn’t come to fruition – and what they learned.

Daniel Cantillon

Adult EP Cardiologist & Chief Medical Officer

Masimo Corporation

Malcolm Finlay

Consultant Cardiologist | Chief Medical Officer | Founder

Barts Heart Centre | Echopoint Medical Ltd | Rhythm AI Ltd

Jennifer N. Avari Silva

Director Pediatric Electrophysiology

Washington University SOM

Avi Fischer, MD, FHRS

Senior Vice President, Medical Affairs and Innovation

Orchestra BioMed, Inc.

September 04, 2025

2025-09-04

02:00 PM (EDT) - 02:45 PM (EDT)

Aileen Ferrick | Jessica Mullenix | Carissa Pistilli | Yekaterina Spivak | Julie Thomas | Amy Tucker | Rebecca Yapejian

In this session, we will delve into the evolving landscape of remote monitoring, addressing the increasing challenges associated with managing vast amounts of data collected from wearables, implantables, and external monitoring devices. We will explore the complexities of integrating data across diverse platforms, with a particular focus on overcoming interoperability barriers.

Jessica Mullenix

Cardiac Electrophysiology Nurse Practitioner

U.S. Department of Veterans Affairs Cardiology Office

Carissa Pistilli

Advanced Nurse Practitioner

Valley Health System

Yekaterina Spivak

Physician Assistant | Inventor & Founder

Children's Hospital of Philadelphia | Laally

Julie Thomas

Electrophysiology Physician Assistant & EP Supervisor

North Shore University Hospital

Amy Tucker

Nurse Manager of the Cardiac Device Clinic

Sanger Heart & Vascular Institute (SHVI)

Rebecca Yapejian

CRM Senior Field Clinical Representative | Cardiac Electrophysiology Nurse Practitioner | Former Software Engineer

Boston Scientific | DOCS Health Careers

Aileen Ferrick

Assistant Director of Cardiac Electrophysiology Research | Acute Care Nurse Practitioner

White Plains Hospital

September 05, 2025

2025-09-05

10:30 AM (EDT) - 11:15 AM (EDT)

Mikhael El-Chami | Neal Bhatia | Janet K. Han

This session will detail the possibilities, potential technologies, and likely pathways for permanent pacing in the future. Specifically, this session will explore next generation pacing technologies, including but not limited to advances in leadless pacing, micro-devices, new epicardial pacing interventions, pacing for HFpE, and physiologic atrial pacing.

Neal Bhatia

Cardiac Electrophysiologist | Co-Director of the Complex Ventricular Tachycardia Ablation Program

Emory University Hospital System

Janet K. Han

Associate Professor of Medicine | Cardiac Electrophysiology

UCLA | VA Greater Los Angeles Healthcare System / UCLA | Digital Health & Virtual Care

Mikhael El-Chami

Electrophysiologist | Professor of Medicine

Emory University

2025-09-05

09:45 AM (EDT) - 10:30 AM (EDT)

Jonathan Piccini | Malcolm Finlay | Marat Fudim | Stavros Stavrakis

The autonomic nervous system is known to play a critical role in the initiation and/or triggering of many arrhythmias, including atrial fibrillation. Autonomic therapies have moved well-beyond isolated ablation of cardiac ganglionated plexi. This session will review the innovations that have expanded autonomic therapies, including tragus stimulation, renal sympathetic denervation, and future innovations for additional interventions.

Malcolm Finlay

Consultant Cardiologist | Chief Medical Officer | Founder

Barts Heart Centre | Echopoint Medical Ltd | Rhythm AI Ltd

Marat Fudim

Associate Professor & Heart Failure Cardiologist

Duke University Medical Center

Stavros Stavrakis

Clinical Electrophysiologist | Associate Professor

Jonathan Piccini

Cardiac Electrophysiologist & Professor of Medicine and Population Health | Director of the Cardiac Electrophysiology section

Duke University Hospital and the Duke Clinical Research Institute | Duke Heart Center

September 04, 2025

2025-09-04

04:30 PM (EDT) - 05:15 PM (EDT)

Amin Al-Ahmad

There is an unprecedented surge in innovation surrounding intracardiac ultrasound and its integration into electrophysiologic care. Future iterations of 4-D intracardiac ultrasound, next-generation integration into mapping systems, and the use of ultrasound for therapeutic purposes all have the potential to significantly change practice. This session will review these key innovations and how they may improve care in the EP laboratory.

Amin Al-Ahmad

Cardiac Electrophysiologist

Texas Cardiac Arrhythmia

2025-09-04

03:45 PM (EDT) - 04:30 PM (EDT)

Natalia Trayanova | Patrick Boyle | Liat Tsoref

Digital twins offer the promise to develop, test, and validate potential personalized solutions for heart rhythm care that are unique to a given individual and their myocardial substrate. Early studies have been promising. However, there are significant challenges from several different areas including operational, computational, and efficacy. This session will engage in discussing whether digital twins will become a foundational core of EP care or remain a fantasy.

Patrick Boyle

Associate Professor of Bioengineering

University of Washington

Liat Tsoref

Senior Director of Digital, AI and Customer Collaboration

Biosense Webster

Natalia Trayanova, PhD, FHRS

Professor | Director for AI Research

Johns Hopkins University